PDCD1LG2 and preeclampsia: Higher expression of PD-L2 is observed in human amniotic mesenchymal stromal cells (hAMSCs) from preeclampsia patients than in hAMSCs from normal pregnant women, but conversely, these cells participate in offsetting the inflammatory environment that characterizes preeclampsia.